Abdul-Aziz, N., Abdulhameed, N., Marellapudi, A., & Shah, H. (2023). Multiple Sclerosis anti-CD20 (Ocrelizumab) therapy inducing hypogammaglobulinemia. Translation: The University of Toledo Journal of Medical Sciences, 11(3). https://doi.org/10.46570/utjms.vol11-2023-836